Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Lucid Diagnostics Inc. | 1,446,763 | reported | 20 Feb 2026 | tx 3+1,320,000 |
| PAVmed Inc. | 167,933 | reported | 30 Sept 2025 | tx 4+450,000−100,935 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 20 Feb 2026 | GRANT_AWARD | Lucid Diagnostics Inc. | 620,000 | 0.00 USD | |
| 30 Sept 2025 | GRANT_AWARD | PAVmed Inc. | 150,000 | 0.00 USD | |
| 20 Feb 2025 | GRANT_AWARD | Lucid Diagnostics Inc. | 300,000 | 0.00 USD | |
| 07 May 2024 | GRANT_AWARD | Lucid Diagnostics Inc. | 400,000 | 0.00 USD | |
| 04 May 2022 | TAX_WITHHOLDING | PAVmed Inc. | 25,935 | 1.38 USD | |
| 22 Feb 2022 | TAX_WITHHOLDING | PAVmed Inc. | 75,000 | 2.43 USD | |
| 22 Feb 2022 | GRANT_AWARD | PAVmed Inc. | 300,000 | 0.00 USD | deriv |